One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Access
PDF Availablehttps://doi.org/10.1016/j.jaci.2016.07.015
Copy DOI
Export
Save
Share
Cite Publication Date: Aug 20, 2016 | |
 Citations: 203 |
Affiliation: Inserm, Sorbonne Paris Cité, Université Paris Cité, Hôpital Necker-Enfants Malades, Vall d'Hebron Hospital Universitari, Institut Pasteur, Hospices Civils de Lyon, Claude Bernard University Lyon 1, Hôpitaux Universitaires Henri-Mondor, École Normale Supérieure de Lyon, International Center for Infectiology Research, French National Centre for Scientific Research, Nuclear Dynamics, University Hospital of Montpellier, Manchester Academic Health Science Centre, University of Manchester, Collège de France
Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 children
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
